Renal Cancer - Results from #2440

The Immunotherapy Landscape in Renal Cell Carcinoma. October 15, 2020

The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management. October 15, 2020

Feasibility, safety and efficacy of argon beam coagulation in robot-assisted partial nephrectomy for solid renal masses ≤ 7 cm in size. October 15, 2020

Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer. October 14, 2020

Safety and oncological outcomes for large (stage ≥T2b) and locally advanced renal cell carcinoma: comparison between laparoscopic and modified hand-assisted laparoscopic radical nephrectomy. October 14, 2020

Nephrometry Scores: Can Preoperative Assessment of Sectional Imaging Really Mirror Intraoperative Renal Tumor Anatomy? October 14, 2020

Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights. October 13, 2020

Functional and oncological outcome of percutaneous cryoablation versus laparoscopic partial nephrectomy for clinical T1 renal tumors: A propensity score-matched analysis. October 13, 2020

Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity. October 13, 2020

PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma. October 12, 2020

Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features. October 12, 2020

SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients. October 12, 2020

Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system. October 9, 2020

Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma. October 9, 2020

Interobserver Variability in Assessment of Renal Mass Biopsies. October 9, 2020

Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry. October 8, 2020

Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance). October 8, 2020

Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including its Variant Morphologies. October 8, 2020

Targeting the HIF2-VEGF axis in renal cell carcinoma. October 8, 2020

From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer. October 7, 2020

Page 123 of 456